^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
Enhertu (fam-trastuzumab deruxtecan-nxki)
i
Other names: DS-8201, DS-8201a, WHO 10516, T-DXd, DS8201, DS 8201, DS8201a, DS 8201a, TDXd, T DXd, WHO10516, WHO-10516
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
AstraZeneca, Daiichi Sankyo
Drug class:
Topoisomerase I inhibitor, HER2-targeted antibody-drug conjugate
Related drugs:
